Abstract
ObjectivesUp to 40% of patients with idiopathic generalised epilepsy (IGE) are drug resistant and potentially could benefit from intracranial neuromodulation of the seizure circuit. We present outcomes following 2 years...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have